Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2016 | Pages:
43 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Toray Industries, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Toray Industries, Inc. - Product Pipeline Review - 2016', provides an overview of the Toray Industries, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Toray Industries, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Toray Industries, Inc. - The report provides overview of Toray Industries, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Toray Industries, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Toray Industries, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Toray Industries, Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Toray Industries, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Toray Industries, Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Toray Industries, Inc. Snapshot 5 Toray Industries, Inc. Overview 5 Key Facts 5 Toray Industries, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Toray Industries, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Pipeline Products - Out-Licensed Products 12 Out-Licensed Products/Combination Treatment Modalities 13 Toray Industries, Inc. - Pipeline Products Glance 14 Toray Industries, Inc. - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Toray Industries, Inc. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Toray Industries, Inc. - Drug Profiles 17 beraprost sodium ER - Drug Profile 17 Product Description 17 Mechanism Of Action 17 R&D Progress 17 GT-0198 - Drug Profile 18 Product Description 18 Mechanism Of Action 18 R&D Progress 18 HIS-388 - Drug Profile 19 Product Description 19 Mechanism Of Action 19 R&D Progress 19 Small Molecule to Agonize Prostacyclin Receptor for Bleeding and Clotting Disorders - Drug Profile 20 Product Description 20 Mechanism Of Action 20 R&D Progress 20 Small Molecule to Antagonize Alpha1B Adrenoceptor - Drug Profile 21 Product Description 21 Mechanism Of Action 21 R&D Progress 21 Small Molecule to Antagonize CCR3 for Undisclosed Indication - Drug Profile 22 Product Description 22 Mechanism Of Action 22 R&D Progress 22 Small Molecule to Block TRPV1 for Overactive Bladder - Drug Profile 23 Product Description 23 Mechanism Of Action 23 R&D Progress 23 Small Molecule to Inhibit Soluble Epoxide Hydrolase for Chronic Kidney Disease - Drug Profile 24 Product Description 24 Mechanism Of Action 24 R&D Progress 24 Small Molecules to Antagonize mGluR5 for Anxiety - Drug Profile 25 Product Description 25 Mechanism Of Action 25 R&D Progress 25 Small Molecules to Inhibit Dipeptidyl Peptidase IV for Type 2 Diabetes - Drug Profile 26 Product Description 26 Mechanism Of Action 26 R&D Progress 26 Small Molecules to Inhibit Soluble Epoxide Hydrolase for Pulmonary Arterial Hypertension - Drug Profile 27 Product Description 27 Mechanism Of Action 27 R&D Progress 27 TRK-390 - Drug Profile 28 Product Description 28 Mechanism Of Action 28 R&D Progress 28 TRK-700 - Drug Profile 29 Product Description 29 Mechanism Of Action 29 R&D Progress 29 Toray Industries, Inc. - Pipeline Analysis 30 Toray Industries, Inc. - Pipeline Products by Target 30 Toray Industries, Inc. - Pipeline Products by Route of Administration 31 Toray Industries, Inc. - Pipeline Products by Molecule Type 32 Toray Industries, Inc. - Pipeline Products by Mechanism of Action 33 Toray Industries, Inc. - Dormant Projects 34 Toray Industries, Inc. - Discontinued Pipeline Products 35 Discontinued Pipeline Product Profiles 35 beraprost sodium SR 35 TAK-363 35 Toray Industries, Inc. - Company Statement 36 Toray Industries, Inc. - Locations And Subsidiaries 37 Head Office 37 Other Locations & Subsidiaries 37 Appendix 42 Methodology 42 Coverage 42 Secondary Research 42 Primary Research 42 Expert Panel Validation 42 Contact Us 42 Disclaimer 43
List of Tables
Toray Industries, Inc., Key Facts 5 Toray Industries, Inc. - Pipeline by Indication, 2016 7 Toray Industries, Inc. - Pipeline by Stage of Development, 2016 8 Toray Industries, Inc. - Monotherapy Products in Pipeline, 2016 9 Toray Industries, Inc. - Partnered Products in Pipeline, 2016 10 Toray Industries, Inc. - Partnered Products/ Combination Treatment Modalities, 2016 11 Toray Industries, Inc. - Out-Licensed Products in Pipeline, 2016 12 Toray Industries, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016 13 Toray Industries, Inc. - Phase II, 2016 14 Toray Industries, Inc. - Preclinical, 2016 15 Toray Industries, Inc. - Discovery, 2016 16 Toray Industries, Inc. - Pipeline by Target, 2016 30 Toray Industries, Inc. - Pipeline by Route of Administration, 2016 31 Toray Industries, Inc. - Pipeline by Molecule Type, 2016 32 Toray Industries, Inc. - Pipeline Products by Mechanism of Action, 2016 33 Toray Industries, Inc. - Dormant Developmental Projects,2016 34 Toray Industries, Inc. - Discontinued Pipeline Products, 2016 35 Toray Industries, Inc., Other Locations 37 Toray Industries, Inc., Subsidiaries 38
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
